59 results found.

HIV Infections Clinical Trial using Current ARV medications; Current TB medications; Current hormonal contraceptive medications

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A or older.
- Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum.
Current ARV medications; Current TB medications; Current hormonal contraceptive medications

Cardiovascular Disease, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults.

AIDS Associated Nephropathy, Focal Glomerulosclerosis, or HIV Inf Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Genetic Markers for Focal Segmental Glomerulosclerosis.

HIV, HIV Infections, or Pregnancy Clinical Trial using TMC114 (darunavir); ritonavir; TMC125 (etravirine); TMC278 (rilpivirine)

Janssen Scientific Affairs, LLC - Recruiting 18 years or older.
- A Single Arm, Open Label Study to Assess the Pharmacokinetics of Darunavir/Ritonavir and/or Etravirine and Rilpivirine in HIV-1 Infected Pregnant Women.
TMC114 (darunavir); ritonavir; TMC125 (etravirine); TMC278 (rilpivirine)

HIV Infections Clinical Trial using Methotrexate (MTX); Placebo; Folic acid

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 40 years or older.
- Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection.
Methotrexate (MTX); Placebo; Folic acid

Tuberculosis, or HIV Infections Clinical Trial using Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 13 years or older.
- Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection.
Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

HIV Infections Clinical Trial using Dolutegravir (DTG) tablet formulation; DTG oral pediatric granules taken as suspension or granules

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A to 17 years.
- Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK1349572, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents.
Dolutegravir (DTG) tablet formulation; DTG oral pediatric granules taken as suspension or granules

HIV-1, HIV Infections, or Acquired Immunodeficiency Syndrome Clinical Trial using E/C/F/TAF; DRV; Pre-existing ARV regimen

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults.
E/C/F/TAF; DRV; Pre-existing ARV regimen

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using E/C/F/TAF

Gilead Sciences - Recruiting 12 years to 17 years.
- A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents.
E/C/F/TAF

HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy.

HIV Infections Clinical Trial using 'Kallunk oxide (Immunotherapy) '

Traditional Alternative Medicine Research, India - Recruiting 8 years to 45 years.
- Phase III Clinical Studies on Traditional CAM Therapy in the Treatment of HIV/AIDS.
'Kallunk oxide (Immunotherapy) '

HIV, Respiratory Infections, Fungal Pneumonia, Viral Pneumonia, o Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections.

HIV Infections Clinical Trial using Cell Transfer

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Immunologic and Virologic Response in HIV Infected Progressors After Infusion of Lymphocytes From HIV Infected 'Elite' Long-Term Non-Progressors.
Cell Transfer

HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients.

HIV Infections, AIDS, or Opportunistic Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection.

Cancer, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 21 years.
- The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study.

HIV Infections, Central Nervous System Neoplasms, or Neurofibroma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Analysis of Stored Data Collected From Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols.

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using Elvitegravir; RTV-boosted PI

Gilead Sciences - Recruiting N/A to 17 years.
- A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG)Administered With a Background-Regimen (BR) Containing a Ritonavir-Boosted Protease Inhibitor (PI/r) in HIV-1 Infected, Antiretroviral Treatment-Experienced Pediatric Subjects.
Elvitegravir; RTV-boosted PI

HIV, or Sexually Transmitted Infections Clinical Trial using Latino STYLE

University of South Florida - Recruiting 14 years or older.
- A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth.
Latino STYLE

HIV Infections Clinical Trial using MK-1439; Efavirenz; TRUVADAr

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- Multicenter, Double-Blind, Randomized, 2-Part, Dose Ranging Study to Compare the Safety, and Antiretroviral Activity of MK-1439 Plus TRUVADA Versus Efavirenz Plus TRUVADA in Antiretroviral Treatment-Naive, HIV-1 Infected Patients.
MK-1439; Efavirenz; TRUVADAr

Parkinson's Disease, or HIV Infections Clinical Trial

KineMed - Recruiting 18 years or older.
- Cellular and Molecular Kinetics of Cerebrospinal Fluid (CSF) Using Heavy Water Labeling Method: A Study of Healthy Controls, CNS HIV Infection, Parkinson's Disease and Other Neurodegenerative Diseases.

Papillomavirus Infections, or HIV Infections Clinical Trial using Oral swabs for HPV-typing and high-risk HPV-determination

Deutsche Luft und Raumfahrt - Recruiting 18 years or older.
- Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men.
Oral swabs for HPV-typing and high-risk HPV-determination

HIV Infections, Papillomavirus Infections, or Anal Intraepithelia Clinical Trial using Smear and biopsy testing for HPV-types and viral load

Deutsche Luft und Raumfahrt - Recruiting 18 years or older.
- Evaluation of Viral Load Determination and Other Biomarkers of High Risk HPV-Types as a Marker for Progression of Perianal HPV-infections in HIV-positive Men Who Have Sex With Men.
Smear and biopsy testing for HPV-types and viral load

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using ATV; DRV; Cobicistat; Background regimen

Gilead Sciences - Recruiting 3 Months to 17 years.
- A Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered With Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects.
ATV; DRV; Cobicistat; Background regimen

Hepatitis C, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications.

Immunodeficiency, Mycobacterial Infection, or Opportunistic Infec Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma.

Acquired Immunodeficiency Syndrome, or HIV Infections Clinical Trial using EVG/COBI/FTC/TDF

Gilead Sciences - Recruiting 12 years to 17 years.
- A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents.
EVG/COBI/FTC/TDF

HIV Infections Clinical Trial

Boehringer Ingelheim Pharmaceuticals - Recruiting 18 years to 64 years.
- Observational Study Assessing the Safety, Efficacy and Treatment Adherence of Nevirapine Extended Release (Combined With Other Antiretroviral Drugs) in HIV Infected Patients in Daily Clinical Practice.

HIV Infections Clinical Trial

University of California, San Francisco - Recruiting 18 years or older.
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era.

HIV Infections Clinical Trial

Gilead Sciences - Recruiting 50 years or older.
- A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects.

HIV Infections Clinical Trial using Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 55 years.
- Cellular Pharmacology of Tenofovir and Emtricitabine for HIV Prophylaxis (Cell Prep).
Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

HIV Infections Clinical Trial using CN54gp140 mixed with GLA-AF

Imperial College London - Recruiting 18 years to 45 years.
- A Phase 1 Open-Labelled Trial to Evaluate the Safety and Immunogenicity of CN54gp140 in HIV-Uninfected, Healthy Volunteers.
CN54gp140 mixed with GLA-AF

HIV Infections Clinical Trial using SeV-G(NP) (0.2mL, 2x10^7 CIU); SeV-G(NP) (0.2mL, 2x10^8 CIU); Ad35-GRIN (0.5mL)

International AIDS Vaccine Initiative - Recruiting 18 years to 50 years.
- A Phase I Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety and Immunogenicity of a Sendai HIV Vaccine SeV-G(NP) Given Intranasally and Ad35-GRIN Administered Intramuscularly in Prime-Boost Regimens in HIV-Uninfected, Healthy Adult Volunteers.
SeV-G(NP) (0.2mL, 2x10^7 CIU); SeV-G(NP) (0.2mL, 2x10^8 CIU); Ad35-GRIN (0.5mL)

HIV Infections, or Hepatitis Clinical Trial

Virginia Commonwealth University - Recruiting 18 years to 90 years.
- HIV-HCV Coinfection: Impact of Immune Dysfunction.

HIV, or Sexually Transmitted Infections Clinical Trial using Connect 'n Unite; Wellness Promotion

Columbia University - Recruiting 18 years or older.
- Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM.
Connect 'n Unite; Wellness Promotion

Sexually Transmitted Diseases, Pregnancy, or HIV Infections Clinical Trial using HIV, STI and Pregnancy Prevention Curriculum; Control Curricula

The University of Texas Health Science Center, Houston - Recruiting 12 years to 14 years.
- It's Your Game...Keep It Real for American Indian/Alaska Native Youth: Innovative Approaches to Prevent Teen Pregnancy Among Underserved Populations.
HIV, STI and Pregnancy Prevention Curriculum; Control Curricula

HIV Infections Clinical Trial using Isentressr; Celsentrir

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer - Recruiting 18 years or older.
- IMPACT OF THERAPY INTENSIFICATION BY AN INTEGRASE INHIBITOR +/- CCR5 INHIBITOR ON THE LYMPHOID RESERVOIR FOR HIV-1 IN CHRONICALLY INFECTED PATIENTS.
Isentressr; Celsentrir

HIV Infections Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 30 years to 55 years.
- Women's Interagency HIV Study (WIHS).

HIV Infections, or Hepatitis C Clinical Trial using Raltegravir; Atazanavir/Ritonavir

St. James's Hospital, Ireland - Recruiting 18 years or older.
- An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-na‹ve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone.
Raltegravir; Atazanavir/Ritonavir

HIV-1, or HIV Infections Clinical Trial using MVA.HIVA

Medical Research Council - Recruiting N/A to 3 Days.
- An Open Randomized Phase I/II Study Evaluating Safety and Immunogenicity of a Candidate HIV-1 Vaccine, MVA.HIVA, Administered to Healthy Infants Born to HIV-1-infected Mothers.
MVA.HIVA

HIV Infections Clinical Trial using generic FDC of TDF/3TC/EFV

The HIV Netherlands Australia Thailand Research Collaboration - Recruiting 18 years or older.
- Generic Fixed Dose Combination (FDC) of Tenofovir(TDF) /Lamivudine(3TC)/Efavirenz (EFV) Tablets 300/300/600 mg.
generic FDC of TDF/3TC/EFV

Tuberculosis, or HIV Infections Clinical Trial using Emtricitabine/tenofovir/efavirenz

African Poverty Related Infection Oriented Research Initiative - Recruiting 18 years to 65 years.
- The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.
Emtricitabine/tenofovir/efavirenz

HIV Infections, or Acquired Immunodeficiency Syndrome Clinical Trial using Structured Ecosystems Therapy (SET)

National Institute of Mental Health (NIMH) - Recruiting 18 years or older.
- Ecosystems Therapy for Men Reintegrating Into Their Family.
Structured Ecosystems Therapy (SET)

HIV, or HIV Infections Clinical Trial using Darunavir, Ritonavir, Truvada; Darunavir, Ritonavir and Etravirine

Imperial College London - Recruiting 18 years or older.
- A Randomised, Open Label, Prospective Study to Assess Two Different Therapeutic Strategies Following First Treatment Failure in HIV-1 Infected Subjects.
Darunavir, Ritonavir, Truvada; Darunavir, Ritonavir and Etravirine

HIV Infections Clinical Trial using Pioglitazone; Observation

University of Texas Southwestern Medical Center - Recruiting 18 years or older.
- Human Immunodeficiency Virus Acquired Lipodystrophy (HAL) Classification, Measurement, & Fat Response to a Thiazolidinedione (TZD) Challenge in Differing Adult Phenotypic Presentations.
Pioglitazone; Observation

HIV, Lung, or HIV Infections Clinical Trial using Smoking Cessation

National Heart, Lung, and Blood Institute (NHLBI) - Recruiting 18 years or older.
- Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV).
Smoking Cessation

HIV, or HIV Infections Clinical Trial using MISC training for primary caregivers

Makerere University - Recruiting 16 Months to 6 years.
- Cognitive and Psychosocial Benefits of Caregiver Training for Ugandan HIV Children.
MISC training for primary caregivers

HIV Infections Clinical Trial using Raltegravir (MK-0518)

University of Pittsburgh - Recruiting 18 years or older.
- Investigating the Source of HIV-1 Viremia in Patients on Antiretroviral Therapy Through Intensification With MK-0518.
Raltegravir (MK-0518)

HIV Infections Clinical Trial

National Taiwan University Hospital - Recruiting 20 years to 60 years.
- The Detection of Drug-Resistant HIV-1 in Taiwan.

HIV Infections Clinical Trial using etanercept

University of Wisconsin, Madison - Recruiting 18 years or older.
- A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease.
etanercept

Infant, Newborn, Diseases, Sepsis, or Puerperal Infection Clinical Trial using Chlorhexidine; Birth canal wipe; sterile water external genital wipe

Centers for Disease Control and Prevention - Recruiting 15 years or older.
- Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa.
Chlorhexidine; Birth canal wipe; sterile water external genital wipe

HIV Infections Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 60 years.
- Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals.

Vitamin D Deficiency, or HIV Infections Clinical Trial using colecalciferol

Radboud University - Recruiting 18 years or older.
- The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients.
colecalciferol

HIV Infections Clinical Trial

Bayside Health - Recruiting N/A or older.
- Role of Naive T-Cells in the Pathogenesis of T-Cell Decline and Long Term Persistence of HIV.

Opiate Dependence, or HIV Infections Clinical Trial using Integrating drug treatment into HIV services

Organization to Achieve Solutions in Substance Abuse (OASIS) - Recruiting 18 years to 85 years.
- SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model.
Integrating drug treatment into HIV services